articleClinical PharmacokineticsMar 10, 2010Closed access

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

JSJoachim StangierKRKarin RathgenHSHildegard StähleDMDago Mazur

Boehringer Ingelheim (Germany)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

722
total citations
FWCI
50.64
Percentile
100%
References
15
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Dabigatran
  • Medicine
  • Pharmacokinetics
  • Pharmacodynamics
  • Cmax
  • Dosing
  • Renal function
  • End stage renal disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.